The price-to-earnings ratio for Smith & Nephew plc ADR (NYSE: SNN) is above average at 40.71x. The 36-month beta value for SNN is also noteworthy at 0.73. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 3 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for SNN is 433.64M, and at present, short sellers hold a 0.48% of that float. The average trading volume of SNN on May 01, 2024 was 975.00K shares.
SNN) stock’s latest price update
Smith & Nephew plc ADR (NYSE: SNN) has seen a rise in its stock price by 1.37 in relation to its previous close of 24.13. However, the company has experienced a -0.45% decline in its stock price over the last five trading sessions. Proactive Investors reported 2024-05-01 that Smith & Nephew jumped to the top of the FTSE 100 as the UK MedTech delivered a confident first-quarter update and reiterated revenues would grow strongly over the remainder of the year. Sales were up by 2.9% on an underlying basis to US$1.39 billion, helped by good performances from orthopaedics (4.4%) and sports medicine (5.5%) with wound management seeing a fall.
SNN’s Market Performance
Smith & Nephew plc ADR (SNN) has seen a -0.45% fall in stock performance for the week, with a 0.78% gain in the past month and a -12.74% plunge in the past quarter. The volatility ratio for the week is 1.50%, and the volatility levels for the past 30 days are at 1.45% for SNN. The simple moving average for the past 20 days is 0.82% for SNN’s stock, with a -7.08% simple moving average for the past 200 days.
SNN Trading at -5.53% from the 50-Day Moving Average
After a stumble in the market that brought SNN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.45% of loss for the given period.
Volatility was left at 1.45%, however, over the last 30 days, the volatility rate increased by 1.50%, as shares sank -0.53% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -14.08% lower at present.
During the last 5 trading sessions, SNN fell by -0.37%, which changed the moving average for the period of 200-days by -20.65% in comparison to the 20-day moving average, which settled at $24.26. In addition, Smith & Nephew plc ADR saw -10.34% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SNN
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.69 for the gross margin
The net margin for Smith & Nephew plc ADR stands at 0.05. The total capital return value is set at 0.1. Equity return is now at value 5.01, with 2.63 for asset returns.
Based on Smith & Nephew plc ADR (SNN), the company’s capital structure generated 0.36 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 0.56. The interest coverage ratio of the stock is 5.49.
Currently, EBITDA for the company is 1.46 billion with net debt to EBITDA at 1.93. When we switch over and look at the enterprise to sales, we see a ratio of 2.43. The receivables turnover for the company is 4.45for trailing twelve months and the total asset turnover is 0.55. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In summary, Smith & Nephew plc ADR (SNN) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
